AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline Digest™: FDA-Approved Biosimilars Outpaces Cell and Gene Therapy Amid Complex Regulatory Challenges
22 oct. 2024 10h00 HE
|
AscellaHealth, LLC
BERWYN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today released its latest...
AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
17 oct. 2024 06h00 HE
|
AscellaHealth, LLC; CHAPPER healthcare
AscellaHealth Announces Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services
Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®
16 oct. 2024 10h00 HE
|
AscellaHealth, LLC
Optime Care Broadens Partnership with Rigel Pharmaceuticals for Expanded Commercial Distribution of TAVALISSE®
U.S. Regulatory Affairs Market Size, Share & Trends Analysis Report 2024-2030 by Services, Category, Indication, Product Stage, Service Provider, Company Size, End-use
11 juil. 2024 10h45 HE
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "U.S. Regulatory Affairs Market Size, Share & Trends Analysis Report by Services, Category, Indication, Product Stage, Service Provider, Company...
Key Growth Opportunities in the Oral Solid Dosage Formulation Industry - Fixed Dose Combination Products for Chronic Diseases, Medical Cannabidiol and Phase-appropriate Services for Orphan Drugs
27 mai 2024 04h35 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Oral Solid Dosage Formulation Industry" report has been added to ResearchAndMarkets.com's offering. This analysis...
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
09 nov. 2023 10h23 HE
|
Open Health
London, Nov. 09, 2023 (GLOBE NEWSWIRE) -- London, UK – November 9, 2023 – OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement,...
Accelerate Your Management Skills with The Pharma Mini MBA Training Course, Tailored for Pharmaceutical Professionals (November 8-10, 2023)
02 nov. 2023 07h38 HE
|
Research and Markets
Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" conference has been added to ResearchAndMarkets.com's offering. A three-day accelerated management programme to...
Indegene and SynPhNe join hands to bring relief to stroke and TBI victims worldwide
16 mai 2023 07h00 HE
|
Indegene Inc
PRINCETON, N.J. and SINGAPORE, May 16, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced today that it is joining hands with SynPhNe, to bring...
Asia-Pacific Pharmaceutical Industry Outlook Report 2023-2027: Top Predictions, Key Trends, Macroeconomic Factors, Revenues, Country-specific Trends, Opportunities
20 avr. 2023 09h18 HE
|
Research and Markets
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Pharmaceutical Industry Outlook 2023" report has been added to ResearchAndMarkets.com's offering. Asia-Pacific's pharmaceutical market...
MMIT Announces Finalists of the Eighth-Annual Specialty Pharmacy Patient Choice Awards
11 avr. 2023 08h00 HE
|
Managed Markets Insight & Technology, LLC
Yardley, PA, April 11, 2023 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner for overcoming barriers to patient access, has announced the...